Sewoon Medical Co., Ltd (KOSDAQ:100700)
South Korea flag South Korea · Delayed Price · Currency is KRW
2,705.00
+85.00 (3.24%)
At close: Apr 2, 2026

Sewoon Medical Ratios and Metrics

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
119,051105,414106,713123,813126,410179,875
Market Cap Growth
13.17%-1.22%-13.81%-2.05%-29.72%-33.94%
Enterprise Value
26,01917,16829,36555,18377,601134,186
Last Close Price
2750.002435.002395.422712.302701.433767.86
PE Ratio
9.868.858.778.2812.1514.65
Forward PE
-16.6116.6116.6116.6116.61
PS Ratio
1.871.661.771.812.102.87
PB Ratio
0.770.680.720.901.011.55
P/TBV Ratio
0.790.700.740.921.041.60
P/FCF Ratio
7.406.559.085.8617.749.35
P/OCF Ratio
6.705.938.095.3713.628.38
EV/Sales Ratio
0.410.270.490.811.292.14
EV/EBITDA Ratio
1.621.071.982.684.836.98
EV/EBIT Ratio
2.051.352.583.266.378.72
EV/FCF Ratio
1.621.072.502.6110.896.97
Debt / Equity Ratio
0.010.010.010.010.010.01
Debt / EBITDA Ratio
0.050.050.070.040.060.04
Debt / FCF Ratio
0.050.050.090.040.150.04
Net Debt / Equity Ratio
-0.62-0.62-0.57-0.54-0.45-0.44
Net Debt / EBITDA Ratio
-6.01-6.01-5.72-3.64-3.48-2.65
Net Debt / FCF Ratio
-5.98-5.98-7.24-3.55-7.85-2.65
Asset Turnover
0.400.400.400.490.470.53
Inventory Turnover
2.222.222.072.282.162.11
Quick Ratio
12.4512.4514.1110.6810.517.84
Current Ratio
14.5814.5817.0313.0113.6810.15
Return on Equity (ROE)
8.04%8.04%8.77%11.78%8.83%11.64%
Return on Assets (ROA)
4.95%4.95%4.69%7.58%5.92%8.21%
Return on Invested Capital (ROIC)
17.78%17.01%14.45%20.58%14.21%17.56%
Return on Capital Employed (ROCE)
8.20%8.20%7.60%12.20%9.70%13.20%
Earnings Yield
10.01%11.30%11.40%12.08%8.23%6.83%
FCF Yield
13.51%15.26%11.01%17.06%5.64%10.70%
Dividend Yield
2.22%--2.58%2.22%1.33%
Payout Ratio
21.80%21.80%24.92%17.37%20.80%17.62%
Buyback Yield / Dilution
1.36%1.36%0.02%---
Total Shareholder Return
3.57%1.36%0.02%2.58%2.22%1.33%
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.